The first reports on thalidomide as a cause of human limb malformation appeared in 196 1.1 2 Despite the active research triggered by these reports, little is known about the aetiology of reduction limb defects in man. In addition to thalidomide, only tetracyclines3 4 and folic acid antagonists5 are suggested as constituting a teratogenic risk to the developing skeletal system. The use of anticonvulsants6 and oral contraceptives7 during pregnancy has also been reported to increase the risk, but other studies fail to support these findings. 8"10 Congenital defects are associated with several infections, but hypoplasia or reduction of the skeletal structures of the limbs has been reported to occur in excess only in connection with herpes simplex,1 varicella, and herpes zoster.12 13 In the collaborative perinatal project"4 advanced maternal age (over 40 years), low birth weight of the child (under 2000 g), and low placental weight (under 300 g) were related to an increased risk of a child's musculoskeletal malformation. In another report reduction limb defect was associated with young parental age and maternal toxaemia.15
In this study some less frequently evaluated factors are examined in relation to the occurrence of reduction limb defect-namely, the outcome of previous pregnancies, an abnormal course of the pregnancy, and the family history. Several statistically significant associations were found.
Material and methods
The material consists of 453 cases of reduction limb defect collected by the Finnish Registry of Congenital Malformations during . In this period a total of 964-878 children over 600 g, including stillbirths, were born in Finland.
The registry is a national surveillance system with data based on reports of all congenital malformations detected in children under 1 The deficiencies have been described in detail."7
The total study group of the reduction limb defects (TRLD) included cases with additional defects of various organs. Thus two subgroups were formed: isolated reduction limb defects with no additional malformations (IRLD, 329 cases) and associated reduction limb defects (ARLD, 124 cases).
The mothers of the children with these defects were interviewed by midwives. Using structured questionnaires they sought information on previous pregnancies, the recent pregnancy, and the family. Records of the particular maternity welfare centres18 that the mothers had visited since early pregnancy were also perused. Thus the information of the events during the pregnancy had been registered before the birth of the malformed child. The questionnaires were completed and other records used for mothers of the controls in an identical way.
The mothers' replies concerning defects in the relatives of the cases were compared with the replies of the mothers of the controls. Often, however, it was not possible to figure out the exact number of relatives. Also two other groups of skeletal defects-namely, polydactyly (559 cases) and syndactyly (299)-both with a known heritable trend, were studied for a familial factor. These cases have been described.17
To measure association between a factor and a defect the statistic "relative risk" was used. A To analyse the effect of vaginal bleeding, the mothers were divided into two groups-those who had vaginal bleeding during pregnancy and those who had not. Among the case-control pairs, the mother of the child with a limb reduction defect had more often had vaginal bleeding than the control mother of the non-malformed child, both during the first trimester of pregnancy and later. Taking the control mothers with no vaginal bleeding as referents, the relative odds for mothers with vaginal bleeding was statistically significantly greater in the total study group (TRLD) and in the subgroup of isolated reduction limb defects (IRLD) ( Threatened abortion (bleeding and pain) during the first trimester was associated with the TRLD and the IRLD. The associations were statistically significant. Threatened abortion during the second or third trimester was most frequent among the mothers of the TRLD and the ARLD cases (table 2) .
To analyse the relationship of reduction limb defect to vaginal bleeding or threatened abortion, or both, during the first trimester (1-14 weeks of gestation), the exact stage of gestation wiias determined ( fig 1) . Of all the 39 cases, in six vaginal bleeding or threatened abortion, or both, occurred before "the sensitive period" of thalidomide-type limb reduction defects, in 17 within the sensitive period, and in 16 after the sensitive period. Most of the later cases (9/7) had major defects or multiple malformations. In 24 cases out of 39 the gestation ended before the 39th week.
DURATION OF GESTATION, PLACENTAL WEIGHT, BIRTH WEIGHT, AND SURVIVAL OF THE CHILD
The duration of the gestation was statistically significantly shorter in the mothers of the TRLD and the IRLD cases (table 3). A short gestation was even more clearly associated with the ARLD (gestation of T Aro, 0 P Heinonen, and L Sax6n Weeks ot gestation 
*Reference category. 37-39 weeks: RO 3.0, CI95 1.5-9'5; gestation of 37 weeks or under: RO 35.0, CI95 13.7-83.0).
Low placental weight was associated with defects in the TRLD and in the subgroup of the IRLD (table  4) . Again, this was most clearly observed in the ARLD subgroup (RO 43 0, CI95 13-4-137-8).
In the TRLD and in the IRLD groups low birth weight was associated with the birth of a defective child (table 5). The highest relative odds for the birth weight of 2500 g or less was observed in the ARLD subgroup (RO 30.0, CIas 12-3-86-8). The largest number in each circle or square has been darkened. If a mother had previously had a malformed child the relative odds were significantly increased (RO 2-8, CI95 1.1-7.4) in the TRLD. In both subgroups the risk was also increased but the confidence intervals included the unity (IRLD RO 2-5, CIs5 0O8-7-7; ARLD RO 4*0, C19s 0.5-30.0). group.bmj.com on April 12, 2017 -Published by http://jech.bmj.com/ Downloaded from
Risk indicators of reduction limb defects
Some of the data are from the antenatal records of the maternity welfare centres, but retrospective information was also obtained in the interviews. Hence, the bias of maternal memory could affect some of the findings.
The association between a variable and a defect in this report may also be false because of the presence of another covariate-that is, a factor showing a closely related matter, such as a mother's age and parity.
A confounding bias rises when some third factor has an effect on a study variable and the occurrence of the defect. The effect of an unknown confounding factor could have been partly reduced by using matched pair controls. Effect of covariants or confounding factors calls for multivariate analysis.
"Vaginal bleeding" and "threatened abortion" may reflect an effort to expel the embryo. This condition was significantly associated with a raised risk of subsequently giving birth to a child with reduction limb defect without or, especially, with, associated malformations. Four alternative explanations for the association can be offered:
either we are dealing with a maternal memory bias,2" a true aetiological factor, a consequence of the abnormal state of the embryo, or an unknown factor is independently causing both malformation and abortion. The explanation by a selective memory bias does not apply here because the information about bleeding and signs of a threatened abortion was derived from the prospective records of the antenatal clinics. Yet the other three alternatives remain, and their analysis meets great difficulties. An effort was made to distinguish between a common cause and a consequence by exploring the stage of pregnancy during bleeding, the assumed phase of skeletogenesis, and also the severity of the defect (fig 1) .
Owing to retrospective analyses of the thalidomide disaster, some information is available on the sensitive period of the reduction limb defects in human embryos. Accordingly, the sixth and seventh weeks of pregnancy seem to be the most vulnerable periods.22 Embryologically, this corresponds with the appearance of the limb buds and of the precartilagineous mesenchymal condensates of the long bones. Towards the end of this period the ossification centres appear. With a certain degree of caution one may conclude that insults during the sixth and seventh weeks of gestation could lead to reduction limb defects, after which actual bone formation might not be prevented, and exogeneous factors may merely impair growth and remodelling of the skeleton. If this contemplation is valid the 23 first cases in fig 1 ( bleeding/threatened abortion before the seventh week of gestation) could reflect an insult 55 manifested both as a threatened abortion and a reduction limb defect, whereas those of later stages can hardly be attributed to a common factor. They should reflect both real efforts to expel a severely defected embryo and merely coincidental phenomena; also the control mothers had occasional bleeding and threatened abortion. The incidence of defects is high among aborted embryos, thus supporting the idea of a natural elimination of defective embryos.
Whether or not vaginal bleeding and threatened abortion reflect a causal teratogenic factor, the fact remains that this disorder should be considered an important indicator for impaired embryogenesis. The conclusion is supported by two previous analyses of the material of the Finnish Registry of Congenital Malformations, where threatened abortion was shown to be associated with a raised risk of defects of the central nervous system and oral clefts.21 23 Short gestation, low placental weight, and low birth weight were associated with an increased risk of all subgroups of reduction limb defect. Most strikingly, the association was in the subgroup of the ARLD, which implies the strong effect of associated malformations. There was also an association with the IRLD, which raises a question of the effect of a third factor. It is not easy to understand why a reduction limb defect would shorten the duration of gestation or have any influence on birth weight or placental weight.
Paternal malformations have been reported to be related to an increased risk of musculoskeletal malformations."4 Here the relation was to malformations in any near relative of the father or the mother.
In the present study a rough and tentative effort was made to examine defects in the near relatives of the affected children further. Only weak trends were detected in the relatives of the children with reduction defects, whereas such were quite obvious in a similar type distribution analysis of the other skeletal defects-syndactyly and polydactyly.
Ignoring the possible memory bias, assuming as many relatives of the cases -as of the controls, and taking these rather small numbers for granted, an attributable risk of a history of reduction limb defect in siblings, parents, their siblings, or grandparents is negligible (3%) among children born with a reduction limb defect. In contrast, any attributable risk of a history of a specific malformation among the cases of syndactyly and polydactyly was about eightfold.
A true genetic analysis of the heredity of reduction limb defects would require a proper family study, whereas these preliminary results suggest that type-specific hereditary factors might have some effect but play no major part in the aetiology of reduction limb defects.
In conclusion, several of the factors analysed in this study showed a statistically significant association with the occurrence of a reduction limb defect. Such risk indicators may prove useful in the future in delineating the maternal "risk groups" for intensive intrauterine surveillance. Furher indicators might be found by exploring maternal diseases and drug consumption when the analysis of this material continues.
